More recently, we observed an increased presence of nuclear RelB in prostate cancer tissues compared to non-neoplastic tissues, thereby suggesting that the alternative NF-κB pathway is also activated during the course of disease progression [10]. The gene discussed is NFKB1; the disease is prostate carcinoma.